HAVN Life Closes First Tranche Of July Financing By ABO, Details On Amendments And Debt Shares Issuance
Biotech psychedelics company HAVN Life Sciences Inc. (OTC:HAVLF) recently closed the initial tranche of its financing pact with innovative fund Alpha Blue Ocean ("ABO"), previously announced on July 2
HAVN Life Sciences announces 1-for-30 reverse stock split
HAVN Life Sciences (OTCPK:HAVLF) announced Friday the reverse stock split at 1-for-30 of its shares. Stock will begin trading on a consolidated basis on August 3, 2022, with a new CUSIP number. As
HAVN Life Announces a 30:1 Consolidation of its Common Shares
VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company" or "HAVN Life") a biotechnology company pursuing standardize
HAVN Life Sciences & Optimi Health Corp Announce Supply Agreements, Here Are The Details
Two publicly traded psychedelics companies announced supply agreements. HAVN Life Sciences (OTC:HAVLF) will provide mental health clinic MPB Group Inc. with psilocybin-containing mushrooms for its the
HAVN Life enters supply agreement with MPB Group
HAVN Life Sciences (OTCPK:HAVLF) enters into a supply partnership with a comprehensive outpatient mental health clinic, MPB Group. MPB Group is partnered with Healing Escapes Foundation retreats, a n
HAVN Life Sciences Inc. to Present at the Planet MicroCap Showcase 2022 in Las Vegas on Wednesday, May 4, 2022
VANCOUVER, BC / ACCESSWIRE / April 30, 2022 / HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE:5NP), a biotechnology company pursuing standardized extraction of psychedelic compounds for investigat
HAVN Life expands supply agreement with Mycotopia Therapies
HAVN Life Sciences (OTCPK:HAVLF) has expanded its supply partnership with Mycotopia Therapies, adding a second supply agreement that covers functional mushrooms, HAVN Life's recently launched natural
HAVN Life Enters Distribution Agreement With Mycrodose Therapeutics For U.S. Market
HAVN Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) (FSE: 5NP), a biotechnology company working with psychedelic compounds for investigational research to support brain health and cognitive function, annou
Havn Life Buys Subscription-Based Functional Mushroom Co. With Significant US Consumer Base
Biotech company Havn Life Sciences Inc. (CSE:HAVN) (OTC:HAVLF) is purchasing functional mushroom wellness brand Spore Life Sciences Inc. The Deal Details Under the deal between HAVN Life, its newly i
HAVN Life Successfully Exports Naturally Derived Psilocybin From Its Jamaica Facility Into Canada
Demonstrating the integrity of its supply chain from Jamaica into Canada, biotechnology company HAVN Life Sciences (OTCPK: HAVLF) achieved a milestone with international delivery - not an easy task. M
Press Release: HAVN Life Announces Departure of Rick Brar as Director
HAVN Life Announces Departure of Rick Brar as Director Canada NewsWire VANCOUVER, BC, Oct. 25, 2021 VANCOUVER, BC, Oct. 25, 2021 /CNW/ - HAVN Life Sciences Inc. (CSE : HAVN) (OTC: HAVLF
Psyched: CaamTech Raises $22M, Mydecine To Launch Smoking Cessation Trial, Michigan Bill Could Decriminalize Psychedelics
Last Week In Psychedelics:CaamTech Raises $22M With A Broad Portfolio Of Novel Psychedelic Drugs Octarine Bio and Clerkenwell Health Partner Up For Clinical Trials Mydecine To Launch Smoking Cessat
HAVN Life Signs Agreement to Supply Psilocybin for Mycotopia Therapies
The partnership will further industry growth for naturally derived psilocybinVANCOUVER, BC / ACCESSWIRE / August 25, 2021 / Havn Life Sciences Inc. (CSE:HAVN)(OTC PINK:HAVLF)(FSE:5NP) (the "Company" o
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public
Psyched: MindMed And Compass Q1 Earnings, FDA Approves Therapists Taking MDMA, Wesana Health Goes Public
No Data